Construction of pBluescript KS+-hPLK
1.25Kb hPLK amplified by RT-PCR with primer P220 and P221 ¡õ Cloned into EcoR V site of pT7Blue by TA cloning ¡õ wild type hPLK sequence is obtained by PCR based site-directed mutagenesis to correct the errors in the sequence. (P239/P240 correct G31.P241/P242 correct T173 to C and G179 to A) ¡õ two mutant hPLK are subsequently made from the wild type 1.25Kb fragment: K82D:P235/P236 change bp 245.K82M hPLK has no kinase activity. AAG for lysine 82 is changed to ATG for methionine. T210D:P245/P246 change bp A627-C628 into G627-A628. T210D hPLK has increased kinase activity. Threonine(ACC)210 is changed to Aspartic acid(GAC)pT7Blue-hPLK WT, K82M,and T210D cut by BamH I ¡õ hPLK BamH I fragment is purified by electoelution ¡÷ product 1
W2C clone(partial hPLK sequence between a.a. 258 to stop codon, in pGAD¡EGH) is cut by BamH I/EcoR I ¡õ hPLK BamH I/EcoRI fragment is purified by gel electroelution ¡õ The W2 fragment is cloned into pBluescript KS+ to form pBlueScript KS+-W2C ¡õ A mutant is made from pBlue KS+-W2C: ¡µKWVD: remove sequence between bp 1237 and bp 1249. The deletion remove K413-W414-V415-D416. These four amino acids are part of consensus polo box sequence.¡µKWVD should disrupt the location of hPLK.pBlue KS+-W2C (WT) and ¡µKWVD are cut with BamH I, treated with cip ¡÷ product 2
hPLK BamH I fragment is purified by electoelution (product 1) + pBlue KS+-W2C (WT) and ¡µKWVD are cut with BamH I, treated with cip (product 2 ) ¡õ complete hPLK sequence in pBluescript KS+ Four construction:WT, K82M, T210D, and ¡µKWVDto abstract